Hypoxia induces NO-dependent release of heparan sulfate in fibroblasts from the Alzheimer mouse Tg2576 by activation of nitrite reduction

Glycobiology
Fang ChengKatrin Mani

Abstract

There is a functional relationship between the heparan sulfate proteoglycan glypican-1 and the amyloid precursor protein (APP) of Alzheimer disease. In wild-type mouse embryonic fibroblasts, expression and processing of the APP is required for endosome-to-nucleus translocation of anhydromannose-containing heparan sulfate released from S-nitrosylated glypican-1 by ascorbate-induced, nitrosothiol-catalyzed deaminative cleavage. In fibroblasts from the transgenic Alzheimer mouse Tg2576, there is increased processing of the APP to amyloid-β peptides. Simultaneously, there is spontaneous formation of anhydromannose-containing heparan sulfate by an unknown mechanism. We have explored the effect of hypoxia on anhydromannose-containing heparan sulfate formation in wild-type and Tg2576 fibroblasts by deconvolution immunofluorescence microscopy and flow cytometry using an anhydromannose-specific monoclonal antibody and by (35)SO4-labeling experiments. Hypoxia prevented ascorbate-induced heparan sulfate release in wild-type fibroblasts, but induced an increased formation of anhydromannose-positive and (35)S-labeled heparan sulfate in Tg2576 fibroblasts. This appeared to be independent of glypican-1 S-nitrosylation as demonstrated by using...Continue Reading

References

Dec 18, 1992·Science·J S StamlerJ Loscalzo
Mar 30, 2001·The Journal of Biological Chemistry·U S KayyaliP M Hassoun
Jun 27, 2002·The Journal of Biological Chemistry·Kan DingLars-Ake Fransson
Apr 28, 2004·Cellular and Molecular Life Sciences : CMLS·L-A FranssonS Sandgren
Aug 3, 2005·Nature Reviews. Molecular Cell Biology·Udo HäckerNorbert Perrimon
Jun 30, 2006·Annual Review of Cell and Developmental Biology·Hannes E Bülow, Oliver Hobert
Mar 9, 2007·Trends in Molecular Medicine·Lars-Ake Fransson, Katrin Mani
Dec 20, 2008·Journal of Alzheimer's Disease : JAD·Carol A ColtonMichael P Vitek
Mar 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Charles A BosworthJack R Lancaster
May 30, 2009·Glycoconjugate Journal·Gabriel Svensson, Katrin Mani
Apr 5, 2011·Annual Review of Neuroscience·Richard J O'Brien, Philip C Wong
Mar 5, 2013·Nitric Oxide : Biology and Chemistry·Nadiezhda Cantu-Medellin, Eric E Kelley
Oct 26, 2013·Neuroscience and Medicine·Zishuo Ian HuWilliam E Van Nostrand
Jun 1, 2014·The Journal of Biological Chemistry·Christian BaruckerGerhard Multhaup
Feb 26, 2015·Antioxidants & Redox Signaling·Rayomand S KhambataAmrita Ahluwalia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.